Delivery Order SPE2DB22D9239-SPE2DB23FDM41

Award Date 9/1/23
Potential Completion Date 9/25/23
Potential Value $73K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $73,000 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 4562369675 XENPOZYME 20 MG VIALS. The single award delivery order was issued against an unspecified governmentwide acquisition contract vehicle and will be performed in Park Ridge, Illinois through October 19, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports America's armed forces by delivering critical supplies such...
The Defense Logistics Agency (DOD) awarded a $72,848 delivery order to DMS Pharmaceutical Group Inc. for 4561567690 XENPOZYME 20 MG VIALS. The firm fixed price order has a period of performance from July 13, 2023 through August 3, 2023, with all work to be completed at the prime contractor's facility located in Park Ridge, Illinois. No set aside designation or subcontracting details were provided. The DLA supports military readiness by procuring and providing logistics support for medical...
The Defense Logistics Agency (DOD) awarded a $72,848.30 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4562136277 units of the drug XENPOZYME in 20 mg vials. The place of performance is Park Ridge, Illinois. The period of performance is from August 30, 2023 through September 21, 2023. No subcontractors or set aside designations were identified. The DLA supports military readiness by procuring and providing logistics support for medical supplies, likely indicating this...
The Defense Logistics Agency (DOD) awarded a $72,848.30 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4561819527 XENPOZYME 20 MG VIALS. The place of performance is Park Ridge, Illinois. The period of performance is from August 3, 2023 through August 24, 2023. As the DLA supports military operations by procuring and providing logistics support for spare parts, supplies, and equipment, this delivery order is likely fulfilling a medical supply requirement to support...
<p>The Defense Logistics Agency awarded a $72,848.30 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 20 mg vials of Xenpozyme, with performance to be completed by November 6, 2023. DMS Pharmaceutical Group Inc. will deliver the requested Xenpozyme products to the Defense Logistics Agency. No set-aside provision was specified for this award made under an unidentified contracting vehicle.</p>
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $109,272.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of XENPOZYME 20 MG VIALS and has an ultimate completion date of April 15, 2024. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, which is valued at up...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) by the Defense Logistics Agency to provide forty-five hundred sixty-three thousand ten vials of XENPOZYME 20 MG. The place of performance will be Park Ridge, Illinois and all work must be completed by December 18, 2023. As a woman-owned small business, DMS Pharmaceutical Group holds an indefinite delivery contract with the...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) by the Defense Logistics Agency. This order is being issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceuticals and medical products to the Defense Logistics Agency with a potential value of up to five million dollars through December 2025. Under this particular...
The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XENPOZYME 20 mg vials. The $109,272.60 contract has a completion date of March 19, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of branded and generic drugs to government agencies, particularly the Department of Veterans Affairs and Department of...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) to DMS Pharmaceutical Group Inc. to supply twenty thousand (20,000) units of XENPOZYME 20 MG VIALS. Performance will take place in Park Ridge, Illinois under a start date of August 2, 2023 and end date of August 23, 2023. As a key logistics combat support agency within the Department of Defense, the Defense Logistics Agency...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB23FDM41
    Delivery Order

The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $72,848 delivery order contract to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the firm fixed price contract, DMS will provide 4562192625 units of 20 mg vials of XENPOZYME pharmaceutical product to the DLA. Performance will take place at the contractor's facility in Park Ridge and span from September 1st through September 25th, 2023. No subcontractors or set aside designations were identified. The delivery order was likely issued against an existing DLA pharmaceuticals contract vehicle to supply this military treatment facility with a needed prescription medication within tight timeframes.

Generated 12/18/23, 4:15 AM